TY - JOUR
T1 - Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients
AU - Gaglia, Jason L.
AU - Guimaraes, Alexander R.
AU - Harisinghani, Mukesh
AU - Turvey, Stuart E.
AU - Jackson, Richard
AU - Benoist, Christophe
AU - Mathis, Diane
AU - Weissleder, Ralph
PY - 2011/1/4
Y1 - 2011/1/4
N2 - Type 1A diabetes (T1D) is an autoimmune disease characterized by leukocyte infiltration of the pancreatic islets of Langerhans. A major impediment to advances in understanding, preventing, and curing T1D has been the inability to "see" the disease initiate, progress, or regress, especially during the occult phase. Here, we report the development of a noninvasive method to visualize T1D at the target organ level in patients with active insulitis. Specifically, we visualized islet inflammation, manifest by microvascular changes and monocyte/macrophage recruitment and activation, using magnetic resonance imaging of magnetic nanoparticles (MNPs). As a proof of principle for this approach, imaging of infused ferumoxtran-10 nanoparticles permitted effective visualization of the pancreas and distinction of recent-onset diabetes patients from nondiabetic controls. The observation that MNPs accumulate in the pancreas of T1D patients opens the door to exploiting this noninvasive imaging method to follow T1D progression and monitoring the ability of immunomodulatory agents to clear insulitis.
AB - Type 1A diabetes (T1D) is an autoimmune disease characterized by leukocyte infiltration of the pancreatic islets of Langerhans. A major impediment to advances in understanding, preventing, and curing T1D has been the inability to "see" the disease initiate, progress, or regress, especially during the occult phase. Here, we report the development of a noninvasive method to visualize T1D at the target organ level in patients with active insulitis. Specifically, we visualized islet inflammation, manifest by microvascular changes and monocyte/macrophage recruitment and activation, using magnetic resonance imaging of magnetic nanoparticles (MNPs). As a proof of principle for this approach, imaging of infused ferumoxtran-10 nanoparticles permitted effective visualization of the pancreas and distinction of recent-onset diabetes patients from nondiabetic controls. The observation that MNPs accumulate in the pancreas of T1D patients opens the door to exploiting this noninvasive imaging method to follow T1D progression and monitoring the ability of immunomodulatory agents to clear insulitis.
UR - http://www.scopus.com/inward/record.url?scp=78650967712&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78650967712&partnerID=8YFLogxK
U2 - 10.1172/JCI44339
DO - 10.1172/JCI44339
M3 - Article
C2 - 21123946
AN - SCOPUS:78650967712
SN - 0021-9738
VL - 121
SP - 442
EP - 445
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 1
ER -